SK15699A3 - Modified oligosaccharides, process for their preparation and pharmaceutical composition containing them - Google Patents
Modified oligosaccharides, process for their preparation and pharmaceutical composition containing them Download PDFInfo
- Publication number
- SK15699A3 SK15699A3 SK156-99A SK15699A SK15699A3 SK 15699 A3 SK15699 A3 SK 15699A3 SK 15699 A SK15699 A SK 15699A SK 15699 A3 SK15699 A3 SK 15699A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- group
- alkyl
- aryl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96810526 | 1996-08-08 | ||
| EP96810527 | 1996-08-08 | ||
| EP96810636 | 1996-09-26 | ||
| PCT/EP1997/004279 WO1998006730A1 (en) | 1996-08-08 | 1997-08-06 | Modified oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK15699A3 true SK15699A3 (en) | 1999-07-12 |
Family
ID=27237868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK156-99A SK15699A3 (en) | 1996-08-08 | 1997-08-06 | Modified oligosaccharides, process for their preparation and pharmaceutical composition containing them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0920437A1 (ko) |
| JP (1) | JP2000516224A (ko) |
| KR (1) | KR20000029862A (ko) |
| CN (1) | CN1227563A (ko) |
| AR (1) | AR008283A1 (ko) |
| AU (1) | AU720381B2 (ko) |
| BR (1) | BR9711117A (ko) |
| CA (1) | CA2260854A1 (ko) |
| CO (1) | CO4900075A1 (ko) |
| CZ (1) | CZ39099A3 (ko) |
| ID (1) | ID18010A (ko) |
| IL (1) | IL127908A0 (ko) |
| NO (1) | NO990497L (ko) |
| NZ (1) | NZ334048A (ko) |
| PE (1) | PE99298A1 (ko) |
| PL (1) | PL331286A1 (ko) |
| SK (1) | SK15699A3 (ko) |
| TR (1) | TR199900245T2 (ko) |
| WO (1) | WO1998006730A1 (ko) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| WO2000044367A2 (en) | 1999-02-01 | 2000-08-03 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| CA2490703A1 (en) * | 2002-07-03 | 2004-01-15 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
| MXPA05003844A (es) | 2002-10-11 | 2005-06-22 | Yamanouchi Europ Bv | Compuestos con base de glucosa con afinidad para p-selectina. |
| CA2546784A1 (en) * | 2003-11-19 | 2005-06-16 | Glycomimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
| WO2006127906A1 (en) * | 2005-05-25 | 2006-11-30 | Glycomimetics, Inc. | Heterobifunctional compounds for selectin inhibition |
| LT2264043T (lt) | 2005-09-02 | 2017-12-11 | Glycomimetics, Inc. | Heterobifunkciniai pan-selektino inhibitoriai |
| NZ598863A (en) * | 2007-02-09 | 2013-11-29 | Glycomimetics Inc | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| AU2008336249B2 (en) | 2007-12-10 | 2015-01-29 | The University Of Queensland | Treatment and prophylaxis |
| WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| WO2012037034A1 (en) | 2010-09-14 | 2012-03-22 | Glycomimetics, Inc. | E-selectin antagonists |
| CA2858099C (en) | 2011-12-22 | 2020-12-15 | Glycomimetics, Inc. | E-selectin antagonist compounds, compositions, and methods of use |
| DK2928476T3 (en) | 2012-12-07 | 2018-05-22 | Glycomimetics Inc | RELATIONSHIPS, COMPOSITIONS AND METHODS OF USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS |
| DK3227310T3 (da) | 2014-12-03 | 2019-09-30 | Glycomimetics Inc | Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer |
| WO2017127422A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
| US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
| WO2018068010A1 (en) | 2016-10-07 | 2018-04-12 | Glycomimetics, Inc. | Highly potent multimeric e-selectin antagonists |
| EP3596096A1 (en) | 2017-03-15 | 2020-01-22 | GlycoMimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
| WO2019108750A1 (en) | 2017-11-30 | 2019-06-06 | Glycomimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
| AU2018395417B2 (en) | 2017-12-29 | 2023-07-13 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| CN108299525B (zh) * | 2018-01-05 | 2021-03-26 | 佛山科学技术学院 | 路易斯寡糖-x的合成方法 |
| CA3091454A1 (en) | 2018-03-05 | 2019-09-12 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| CN109762032A (zh) * | 2019-01-16 | 2019-05-17 | 天津科技大学 | 一种磺酸化路易斯x三糖及其合成方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993023031A1 (en) * | 1992-05-08 | 1993-11-25 | The Biomembrane Institute | Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
| WO1994020514A1 (en) * | 1993-03-04 | 1994-09-15 | Mect Corporation | Lewis-associated compound, process for producing the same, and anti-inflammatory |
| JPH08510729A (ja) * | 1993-05-14 | 1996-11-12 | サイテル コーポレイション | 細胞接着のインヒビターとしてのシアリルＬｅ▲上ｘ▼類似体 |
| CA2209084A1 (en) * | 1994-12-28 | 1996-07-04 | Hiroshi Miyauchi | Lewis x derivative and process for producing the same |
-
1997
- 1997-08-06 CN CN97197077A patent/CN1227563A/zh active Pending
- 1997-08-06 AU AU43788/97A patent/AU720381B2/en not_active Ceased
- 1997-08-06 NZ NZ334048A patent/NZ334048A/xx unknown
- 1997-08-06 JP JP10509358A patent/JP2000516224A/ja active Pending
- 1997-08-06 CA CA002260854A patent/CA2260854A1/en not_active Abandoned
- 1997-08-06 PL PL97331286A patent/PL331286A1/xx unknown
- 1997-08-06 SK SK156-99A patent/SK15699A3/sk unknown
- 1997-08-06 BR BR9711117-1A patent/BR9711117A/pt not_active Application Discontinuation
- 1997-08-06 IL IL12790897A patent/IL127908A0/xx unknown
- 1997-08-06 WO PCT/EP1997/004279 patent/WO1998006730A1/en not_active Application Discontinuation
- 1997-08-06 CZ CZ99390A patent/CZ39099A3/cs unknown
- 1997-08-06 KR KR1019997001025A patent/KR20000029862A/ko not_active Application Discontinuation
- 1997-08-06 TR TR1999/00245T patent/TR199900245T2/xx unknown
- 1997-08-06 EP EP97941916A patent/EP0920437A1/en not_active Withdrawn
- 1997-08-06 AR ARP970103580A patent/AR008283A1/es unknown
- 1997-08-07 PE PE1997000688A patent/PE99298A1/es not_active Application Discontinuation
- 1997-08-08 ID IDP972766A patent/ID18010A/id unknown
- 1997-08-08 CO CO97045596A patent/CO4900075A1/es unknown
-
1999
- 1999-02-03 NO NO990497A patent/NO990497L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ334048A (en) | 2000-05-26 |
| BR9711117A (pt) | 1999-09-08 |
| ID18010A (id) | 1998-02-19 |
| PE99298A1 (es) | 1999-01-21 |
| WO1998006730A1 (en) | 1998-02-19 |
| EP0920437A1 (en) | 1999-06-09 |
| PL331286A1 (en) | 1999-07-05 |
| IL127908A0 (en) | 1999-11-30 |
| KR20000029862A (ko) | 2000-05-25 |
| JP2000516224A (ja) | 2000-12-05 |
| CN1227563A (zh) | 1999-09-01 |
| NO990497D0 (no) | 1999-02-03 |
| CA2260854A1 (en) | 1998-02-19 |
| AU4378897A (en) | 1998-03-06 |
| CZ39099A3 (cs) | 1999-05-12 |
| NO990497L (no) | 1999-03-24 |
| AU720381B2 (en) | 2000-06-01 |
| TR199900245T2 (xx) | 1999-05-21 |
| CO4900075A1 (es) | 2000-03-27 |
| AR008283A1 (es) | 1999-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK15699A3 (en) | Modified oligosaccharides, process for their preparation and pharmaceutical composition containing them | |
| US11919921B2 (en) | Galactoside inhibitor of galectins | |
| JP3915116B2 (ja) | 新規ピラゾール誘導体及びそれらを含有する糖尿病治療薬 | |
| CA1218647A (en) | Difluoro antivirals and intermediate therefor | |
| JP4553488B2 (ja) | カルボキシメチルガラクトース誘導体 | |
| JPS61148193A (ja) | 腫瘍治療剤 | |
| SK177897A3 (en) | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a | |
| EP3245216B1 (en) | Novel galactoside inhibitor of galectins | |
| EP0912613B1 (fr) | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| JPH0899989A (ja) | 新規糖脂質誘導体およびその製造用中間体 | |
| EP0801071A1 (en) | Lewis x derivative and process for producing the same | |
| EP3819302B1 (en) | Fucosylated chondroitin sulfate oligosaccharide, preparation method therefor, composition thereof and use thereof | |
| JPH05194602A (ja) | 硫酸化グリコサミノグリカノイド誘導体 | |
| CA2442979C (en) | Process for the preparation of 2'-halo-.beta.-l-arabinofuranosyl nucleosides | |
| JPH09183789A (ja) | 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途 | |
| CA2204204C (en) | Carbohydrate derivatives | |
| EP2852607B1 (en) | Synthesis of steroid saponins | |
| MXPA99001287A (en) | Modified oligosaccharides | |
| JPH09301988A (ja) | グルコサミン誘導体 | |
| JP4591781B2 (ja) | 新規ピラゾール誘導体及びそれらを含有する糖尿病治療薬 | |
| JPH0948792A (ja) | ルイスｘ誘導体 | |
| JPH1045793A (ja) | 二量体化合物 |